A consumer's guide for probiotics: 10 golden rules for a correct use

Digestive and Liver Disease

Volumn 49, Issue 11, 2017, Pages 1177-1184

  Toscano, Marco ^a   De Grandi, Roberta ^a   Pastorelli, Luca ^a,b   Vecchi, Maurizio ^a,b   Drago, Lorenzo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

Anti inflammatory response; Gut microbiota; Multistrain products

Indexed keywords

PROBIOTIC AGENT; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL GENE; BACTERIAL METABOLISM; BACTERIAL SPORE; BACTERIAL STRAIN; CELL LYSATE; DRUG EFFICACY; DRUG SAFETY; HEALTH STATUS; HUMAN; INTESTINE FLORA; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STOMACH PH; EVIDENCE BASED MEDICINE; GASTROINTESTINAL TRACT; MICROBIOLOGY; NOMENCLATURE; ORGANISMAL INTERACTION;

DRUG RESISTANCE, BACTERIAL; EVIDENCE-BASED MEDICINE; GASTROINTESTINAL TRACT; HUMANS; MICROBIAL INTERACTIONS; PRACTICE GUIDELINES AS TOPIC; PROBIOTICS; TERMINOLOGY AS TOPIC;

EID: 85027693805     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2017.07.011     Document Type: Review

References (88)

1. Sonal Sekhar, M., Unnikrishnan, M.K., Vijayanarayana, K., Rodrigues, G.S., Mukhopadhyay, C., Topical application/formulation of probiotics: will it be a novel treatment approach for diabetic foot ulcer?. Med Hypotheses 82 (2014), 86–88.
2. Chong, E.S., A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action. World J Microbiol Biotechnol 30 (2014), 351–374.
3. Drago, L., Toscano, M., De Vecchi, E., Piconi, S., Iemoli, L., Changing of fecal flora and clinical effect of L. salivarius LS01 in adults with atopic dermatitis. J Clin Gastroenterol 46 (2012), S56–S63.
4. Drago, L., Toscano, M., Pigatto, P.D., Probiotics: immunomodulatory properties in allergy and eczema. G Ital Dermatol Venereol 48 (2013), 505–514.
5. Corridoni, D., Pastorelli, L., Mattioli, B., Locovei, S., Ishikawa, D., Arseneau, K.O., et al. Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism. PLoS One, 7, 2012, e42067.
6. Pastorelli, L., De Salvo, C., Mercado, J.R., Vecchi, M., Pizarro, T.T., Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics. Front Immunol, 4, 2013, 280.
7. Chapman, C.M., Gibson, G.R., Rowland, I., In vitro evaluation of single- and multi-strain probiotics: inter-species inhibition between probiotic strains, and inhibition of pathogens. Anaerobe 18 (2012), 405–413.
8. Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., et al. Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.
9. Stappenbeck, T.S., Hooper, L.V., Gordon, J.I., Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 99 (2002), 15451–15455.
10. Bäckhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101 (2004), 15718–15723.
11. Sekirov, I., Russell, S.L., Antunes, L.C., Finlay, B.B., Gut microbiota in health and disease. Physiol Rev 90 (2010), 859–904.
12. Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. 2001, Food and Agriculture Organization of the United Nations, World Health Organization.
13. Reid, G., Probiotics: definition, scope and mechanisms of action. Best Pract Res Clin Gastroenterol 30 (2016), 17–25.
14. Adams, C.A., The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev 23 (2010), 37–46.
15. Sakai, Y., Tsukahara, T., Bukawa, W., Matsubara, N., Ushida, K., Cell preparation of Enterococcus faecalis strain EC-12 prevents vancomycin-resistant enterococci colonization in the cecum of newly hatched chicks. Poult Sci 85 (2006), 273–277.
16. Marin, M.L., Lee, J.H., Ustunol, M.Z., Differential cytokine production in clonal macrophage and T-cell lines cultured with bifidobacteria. J Dairy Sci 80 (1997), 2713–2720.
17. Chuang, L., Wu, K.G., Pai, C., Hsieh, P.S., Tsai, J.J., Yen, J.H., et al. Heat-killed cells of lactobacilli skew the immune response toward T helper 1 polarization in mouse splenocytes and dendritic cell-treated T cells. J Agric Food Chem 55 (2007), 11080–11086.
18. Pessi, T., Sütas, Y., Saxelin, M., Kallioinen, H., Isolauri, E., Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria. Appl Environ Microbiol 65 (1999), 4725–4728.
19. Salinas, I., Meseguer, J., Esteban, Á., Antiproliferative effects and apoptosis induction by probiotic cytoplasmic extracts in fish cell lines. Vet Microbiol 126 (2008), 287–294.
20. Miura, N.N., Ohno, N., Aketagawa, J., Tamura, H., Tanaka, S., Yadomae, T., Blood clearance of (1–>3)-beta-D-glucan in MRL lpr/lpr mice. FEMS Immunol Med Microbiol 13 (1996), 51–57.
21. Lau, S., Bacterial lysates in food allergy prevention. Curr Opin Allergy Clin Immunol 13 (2013), 293–295.
22. Hong, H.A., Duc le, H., Cutting, S.M., The use of bacterial spore formers as probiotics. FEMS Microbiol Rev 29 (2005), 813–835.
23. Klaenhammer, T.R., Kullen, M.J., Selection and design of probiotics. Int J Food Microbiol 50 (1999), 45–57.
24. Giroux, S., Cedergren, R., Evolution of a tRNA operon in gamma purple bacteria. J Bacteriol 171 (1989), 6446–6454.
25. Weese, J.S., Evaluation of deficiencies in labeling of commercial probiotics. Can Vet J 44 (2003), 982–983.
26. Toscano, M., de Vecchi, E., Rodighiero, V., Drago, L., Microbiological and genetic identification of some probiotics proposed for medical use in 2011. J Chemother 25 (2013), 156–161.
27. Chapman, C.M., Gibson, G.R., Rowland, I., Health benefits of probiotics: are mixtures more effective than single strains?. Eur J Nutr 50 (2011), 1–17.
28. Drago, L., De Vecchi, E., Gabrieli, A., De Grandi, R., Toscano, M., Immunomodulatory effects of Lactobacillus salivarius LS01 and Bifidobacterium breve BR03, alone and in combination, on peripheral blood mononuclear cells of allergic asthmatics. Allergy Asthma Immunol Res 7 (2015), 409–413.
29. Drago, L., Gismondo, M.R., Lombardi, A., de Haën, C., Gozzini, L., Inhibition of in vitro growth of enteropathogens by new Lactobacillus isolates of human intestinal origin. FEMS Microbiol Lett 153 (1997), 455–463.
30. Collado, M.C., Isolauri, E., Salminen, S., Specific probiotic strains and their combinations counteract adhesion of Enterobacter sakazakii to intestinal mucus. FEMS Microbiol Lett 285 (2008), 58–64.
31. Timmerman, H.M., Koning, C.J., Mulder, L., Rombouts, F.M., Beynen, A.C., Monostrain, multistrain and multispecies probiotics—a comparison of functionality and efficacy. Int J Food Microbiol 96 (2004), 219–233.
32. Vitali, B., Candela, M., Matteuzzi, D., Quantitative detection of probiotic Bifidobacterium strains in bacterial mixtures by using real-time PCR. Syst Appl Microbiol 26 (2003), 269–276.
33. Wong, A., Ngu, D.Y., Dan, L.A., Ooi, A., Lim, R.L., Detection of antibiotic resistance in probiotics of dietary supplements. Nutr J, 14, 2015, 95.
34. EFSA, The maintenance of the list of QPS microorganisms intentionally added to food or feed—scientific opinion of the panel on biological hazards. EFSA J 923 (2008), 1–48.
35. Toscano, M., Peroni, D.G., De Vecchi, E., Mattina, R., PDrago, L., Microbiological assessment of some powdered infant formulas: from quality to antibiotic resistance evaluation. J Food Process Technol, 4, 2013, 12.
36. Ventola, C.L., The antibiotic resistance crisis: part 1: causes and threats. Pharm Ther 40 (2015), 277–283.
37. Deege, M.P., Paterson, D.L., Reducing the development of antibiotic resistance in critical care units. Curr Pharm Biotechnol 12 (2011), 2062–2069.
38. Drago, L., Mattina, R., De Vecchi, E., Toscano, M., Phenotypic and genotypic antibiotic resistance in some probiotics proposed for medical use. Int J Antimicrob Agents 41 (2013), 396–397.
39. Drago, L., De Grandi, R., De Vecchi, E., Toscano, M., Antibiotic susceptibility profile of a new Lactobacillus kefiri strain. J Glob Antimicrob Resist 4 (2016), 74–75.
40. Collado, M.C., Sanz, Y., Induction of acid resistance in Bifidobacterium: a mechanism for improving desirable traits of potentially probiotic strains. J Appl Microbiol 103 (2007), 1147–1157.
41. De Angelis, M., Bini, L., Pallini, V., Cocconcelli, P.S., Gobbetti, M., The acid-stress response in Lactobacillus sanfranciscensis CB1. Microbiology 147 (2001), 1863–1873.
42. Jan, G., Leverrier, P., Pichereau, V., Boyaval, P., Changes in protein synthesis and morphology during acid adaptation of Propionibacterium freudenreichii. Appl Environ Microbiol 67 (2001), 2029–2036.
43. Matsumoto, M., Ohishi, H., Benno, Y., H+-ATPase activity in Bifidobacterium with special reference to acid tolerance. Int J Food Microbiol 93 (2004), 109–113.
44. Amachi, S., Ishikawa, K., Toyoda, S., Kagawa, Y., Yokota, A., Tomita, F., Characterization of a mutant of Lactococcus lactis with reduced membrane-bound ATPase activity under acidic conditions. Biosci Biotechnol Biochem 62 (1998), 1574–1580.
45. Toscano, M., De Vecchi, E., Gabrieli, A., Drago, L., Probiotic characteristics and in vitro compatibility of a combination of Bifidobacterium breve M-16 V, Bifidobacterium longum subsp. infantis M-63 and Bifidobacterium longum subsp. longum BB536. Ann Microbiol 65 (2015), 1079–1086.
46. Elkins, C.A., Savage, D.C., Identification of genes encoding conjugated bile salt hydrolase and transport in Lactobacillus johnsonii 100-100. J Bacteriol 180 (1998), 4344–4349.
47. Elkins, C.A., Moser, S.A., Savage, D.C., Genes encoding bile salt hydrolases and conjugated bile salt transporters in Lactobacillus johnsonii 100-100 and other Lactobacillus species. Microbiology 147 (2001), 3403–3412.
48. Grill, J.P., Manginot-Dürr, C., Schneider, F., Bifidobacteria and probiotic effects: action of Bifidobacterium species on conjugated bile salts. Curr Microbiol 31 (1995), 23–27.
49. Grill, J., Schneider, F., Crociani, J., Ballongue, J., Purification and characterization of conjugated bile salt hydrolase from Bifidobacterium longum BB536. Appl Environ Microbiol 61 (1995), 2577–2582.
50. Franz, C.M., Specht, I., Haberer, P., Holzapfel, W.H., Bile salt hydrolase activity of Enterococci isolated from food: screening and quantitative determination. J Food Prot 64 (2001), 725–729.
51. Begley, M., Hill, C., Gahan, C.G., Bile salt hydrolase activity in probiotics. Appl Environ Microbiol 72 (2006), 1729–1738.
52. Sahadeva, R.P.K., Leong, S.F., Chua, K.H., Tan, C.H., Chan, H.Y., Survival of commercial probiotic strains to pH and bile. Int Food Res J 18 (2001), 1515–1522.
53. Jacobsen, C.N., Rosenfeldt Nielsen, V., Hayford, A.E., Møller, P.L., Michaelsen, K.F., Paerregaard, A., Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 65 (1999), 4949–4956.
54. Oelschlaeger, T.A., Mechanisms of probiotic actions—a review. Int J Med Microbiol 300 (2010), 57–62.
55. Beikler, T., Flemmig, T.F., Oral biofilm-associated diseases: trends and implications for quality of life, systemic health and expenditures. Periodontology 55 (2011), 87–103.
56. Gomaa Zakaria, E., Antimicrobial and anti-adhesive properties of biosurfactant produced by lactobacilli isolates, biofilm formation and aggregation ability. J Gen Appl Microbiol 59 (2013), 425–436.
57. Dommels, Y.E., Kemperman, R.A., Zebregs, Y.E., Draaisma, R.B., Jol, A., Wolvers, D.A., Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread. Appl Environ Microbiol 75 (2009), 6198–6204.
58. Prilassnig, M., Wenisch, C., Daxboeck, F., Feierl, G., Are probiotics detectable in human feces after oral uptake by healthy volunteers?. Wien Klin Wochenschr 119 (2007), 456–462.
59. Viggiano, D., Ianiro, G., Vanella, G., Bibbò, S., Bruno, G., Simeone, G., Gut barrier in health and disease: focus on childhood. Eur Rev Med Pharmacol Sci 19 (2015), 1077–1085.
60. Kristensen, N.B., Bryrup, T., Allin, K.H., Trine, N., Hansen, T.H., Pederson, O., Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med, 8, 2016, 52.
61. Mayor, S., Probiotics have no effect on gut microbiota in healthy people, review suggests. BMJ, 353, 2016, i2617.
62. Drago, L., Toscano, M., De Vecchi, E., Piconi, S., Iemoli, E., Changing of fecal flora and clinical effect of L. salivarius LS01 in adults with atopic dermatitis. J Clin Gastroenterol 46 (2012), S56–S63.
63. Fuller, R., Gibson, G.R., Modification of the intestinal microflora using probiotics and prebiotics. Scand J Gastroenterol 32 (1997), 28–31.
64. Goldin, B.R., Gorbach, S.L., Saxelin, M., Barakat, S., Gualtieri, L., Salminen, S., Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci 37 (1992), 121–128.
65. Papadimitriou, K., Zoumpopoulou, G., Foligné, B., Alexandraki, V., Kazou, M., Pot, B., et al. Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches. Front Microbiol, 6, 2015, 58.
66. De Groote, M.A., Frank, D.N., Dowell, E., DGlode, M.P., Pace, N.R., Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 24 (2005), 278–280.
67. Vahabnezhad, E., Mochon, A.B., Wozniak, L.J., Ziring, D.A., Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J Clin Gastroenterol 47 (2013), 437–439.
68. Sawh, S.C., Deshpande, S., Jansen, S., Reynaert, C.J., Jones, P.M., Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis. PeerJ, 4, 2016, e2429.
69. Sullivan, S., Schanler, R.J., Kim, J.H., Patel, A.L., Trawöger, R., Kiechl-Kohlendorfer, U., et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 156 (2010), 562–567.
70. Meinzen-Derr, J., Poindexter, B., Wrage, L., Morrow, A.L., Stoll, B., Donovan, E.F., Role of human milk in extremely low birth weight infants’ risk of necrotizing enterocolitis or death. J Perinatol 29 (2009), 57–62.
71. Zhang, Q., Wu, Y., Fei, X., Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Medicina (Kaunas) 52 (2016), 28–34.
72. Ma, Y.Y., Li, L., Yu, C.H., Shen, Z., Chen, L.H., Li, Y.M., Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol 19 (2013), 6911–6918.
73. Nikbakht, E., Khalesi, S., Singh, I., Williams, L.T., West, N.P., Colson, N., Effect of probiotics and synbiotics on blood glucose: a systematic review and meta-analysis of controlled trials. Eur J Nutr, 2016.
74. Niccoli, A.A., Artesi, A.L., Candio, F., Ceccarelli, S., Cozzali, R., Ferraro, L., et al. Preliminary results on clinical effects of probiotic Lactobacillus salivarius LS01 in children affected by atopic dermatitis. J Clin Gastroenterol 48 (2014), S34–S36.
75. Manichanh, C., Borruel, N., Casellas, F., Guarner, F., The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 9 (2012), 599–608.
76. Van Assche, G., Dignass, A., Bokemeyer, B., Danese, S., Gionchetti, P., Moser, G., et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 7 (2013), 1–33.
77. Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119 (2000), 305–309.
78. Mimura, T., Rizzello, F., Helwig, U., Poggioli, G., Schreiber, S., Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53 (2004), 108–114.
79. Li, K.Y., Wang, J.L., Wei, J.P., Gao, S.Y., Zhang, Y.Y., Wang, L.T., et al. Fecal microbiota in pouchitis and ulcerative colitis. World J Gastroenterol 22 (2016), 8929–8939.
80. Kruis, W., Schütz, E., Fric, P., Fixa, B., Judmaier, G., Stolte, M., et al. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11 (1997), 853–858.
81. Rembacken, B.J., Snelling, A.M., Hawkey, P.M., Chalmers, D.M., Axon, A.T., Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354 (1999), 635–639.
82. Kruis, W., Fric, P., Pokrotnieks, J., Lukás, M., Fixa, B., Kascák, M., et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53 (2004), 1617–1623.
83. Ritchie, M.L., Romanuk, T.N., A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One, 7, 2012, e34938.
84. Currò, D., Ianiro, G., Pecere, S., Bibbò, S., Cammarota, G., Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. Br J Pharmacol 174 (2017), 1426–1449.
85. Scully, P., Macsharry, J., O'Mahony, D., Lyons, A., O'Brien, F., Murphy, S., et al. Bifidobacterium infantis suppression of Peyer's patch MIP-1alpha and MIP-1beta secretion during Salmonella infection correlates with increased local CD4 + CD 25+ T cell numbers. Cell Immunol 281 (2013), 134–140.
86. King, T.S., Elia, M., Hunter, J.O., Abnormal colonic fermentation in irritable bowel syndrome. Lancet 352 (1998), 1187–1189.
87. Horvath, A., Dziechciarz, P., Szajewska, H., Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther 33 (2011), 1302–1310.
88. Tiequn, B., Guanqun, C., Shuo, Z., Therapeutic effects of Lactobacillus in treating irritable bowel syndrome: a meta-analysis. Intern Med 54 (2015), 243–249.